New partner brings valuable expertise to the table: Biopharma company PTC Therapeutics joins Screen4Care

Accelerating rare disease diagnostics through genetic newborn screening and digital solutions.

Since launching in October 2021, Screen4Care is dedicated to shorten the diagnosis journey for people l...

Screen4Care workshop on legal, ethical and business-related issues in Bern

On 22 April, the members of Work Package 1 met in Bern to discuss legal, ethical and business-related issues. The workshop was held in hybrid form with online and offline groups in the new building...

EURORDIS' Rare Barometer Survey on the Journey to Diagnosis for People Living with a Rare Disease

Screen4Care’s key partner EURORDIS has launched the Rare Barometer survey – an international survey on the journey to diagnosis for people living with a rare disease. The survey is open to people...

New EU Research Project “Screen4Care”

Accelerating Diagnosis for Rare Disease Patients Through Genetic Newborn Screening and Artificial Intelligence

The international consortium aims to tackle the major hurdle for rare disease patients...